Publication | Closed Access

A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors

OncologyMedicinePharmacokinetic StudyAdvanced Solid TumorsPharmacotherapy30-Min InfusionAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer Research